Clinical Psychopharmacology and Neuroscience indexed in CAS, DOI/Crossref, EMBASE, Korea Citation Index (KCI), KoreaMed, Korea Medical Citation Index (KoMCI), PubMed, PubMed Central (PMC), SCOPUS, SCI-expanded (SCIE), and Google Scholar:eISSN 2093-4327   pISSN 1738-1088

Download original image
Fig. 1. Schematic diagram of microglia and immunomodulatory treatments. Maternal immune activation (MIA) during pregnancy may be bridged to an increased risk of autistic behaviors in the offspring by defective microglial activation. Microglial activation results in the production of pro-inflammatory cytokines such as interleukin (IL)-1β, IL-6 and tumor necrosis factor (TNF)-α. Luteolin, minocycline, and suramin have been shown to block microglial activation and attenuate the levels of inflammatory cytokines. Vitamin D and gut microbiota are believed to reduce pro-inflammatory cytokines released from microglia.
Clinical Psychopharmacology and Neuroscience 2018;16:246~252
© Clin Psychopharmacol Neurosci